Virtual Interaction With Experts: Exploring Novel Therapeutics in Acute Myeloid Leukemia

Download All
In this virtual program, faculty experts explore the use of investigational immunotherapeutic agents, including monoclonal antibody–based therapy, immune checkpoint inhibitors, vaccines, and adoptive cell–based therapy in treating patients with AML. Management of treatment-related toxicities will also be presented.
person default
Richard Dillon, MD
Guillermo Garcia-Manero, MD

Downloadable Slidesets

Download these slides to review expert insights on the standard of care treatments for elderly patients with AML in 2020

Guillermo Garcia-Manero, MD Released: July 16, 2020

Download these slides to review expert insights on latest developments in treatment of AML

person default Richard Dillon, MD Released: July 16, 2020

On Demand Webcast

In this interactive on-demand Webcast, expert hematologists Guillermo Garcia Manero, MD, and Richard Dillon, MD, discuss novel therapeutics in the treatment of acute myeloid leukemia, including the standard of care therapy for patients with AML and incorporation of HDAC inhibitors into their care, and new investigational agents and combinations for AML.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue